"Many consumer groups are concerned that for FDA and the public to be confident in the objectivity of the advice FDA receives, every effort must be made to minimize the number of conflicted experts that serve on these committees."
"I am supportive of its passage."
"Are there any new authorities that would help the FDA in making sure that companies meet those responsibilities?"
"So it is more a question of the resources than new authority then?"
"I appreciate the industry's ability to work with the FDA and move forward on a strong agreement."
"Thank you, Chairman Pitts."
"Both you and the FDA Commissioner Hamburg gave assurances to the generic industry that the Biosimilar User Fee Program would receive 20 million in funding."
"Thank you. Now, would it be helpful to have additional resources to conduct more foreign inspections of brand facilities?"
"As you know, Mr. Dingell, Ms. DeGette, myself, and Mr. Waxman have introduced the Drug Safety Enhancement Act that gives the FDA authorities and resource to address the problem of these ingredients an..."
"We are going to move forward with them."
"Clearly, bringing generic drugs to market faster should be a priority."